Ballicules.com

Loxapine inhaled

ADASUVE

What it isInhaled loxapine (ADASUVE, 2012) — single-use Staccato inhaler, IV-like speed without a needle for acute agitation; REMS: bronchospasm risk, contraindicated in asthma/COPD.

Why this oneSame molecule and receptor pharmacology as the parent card — the formulation (and its label) is the difference.

What limits itClass warnings of the parent molecule apply unchanged.

FDA-approved for

FDA label

BOXED WARNING Bronchospasm (potential respiratory distress/arrest), available only via ADASUVE REMS; increased mortality in elderly with dementia-related psychosis.
FDA dosingPopulationStartTargetMax
Acute agitation associated with schizophrenia or bipolar I disorderAdults10 mg by oral inhalation, single dose10 mg per 24 h (single dose only)

Renal Undefined

Hepatic Undefined

Only a single dose within any 24-hour period

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Third-trimester exposure risks extrapyramidal/withdrawal symptoms in neonates; data insufficient for birth-defect risk.

Lactation No human data; consider benefits of breastfeeding vs. maternal need and potential infant effects.

⚠ BOXED WARNING

Classes and tags

Clinical profile

Direct muscarinic antagonism1 / 4

Active metabolites

Mechanism of action: Loxapine inhaled ballicule

Loxapine inhaled ballicule: receptor binding, kinetics and half-life diagram

Open Loxapine inhaled in the interactive console ↗

Memory aids: mascots and interaction avatars

Loxapine inhaled ADASUVE mascot mnemonic cartoon
“Air to soothe”
Loxapine mascot: “Lotsa ping, Lotsa Tang”
Spooky mascot → antipsychotic
Loxapine inhaled Box: minimal PK interactions avatar
Box: minimal PK interactions

Open Loxapine inhaled in the interactive console ↗